Altogether our results showed the effects of ibrutinib and acalabrutinib in modulating CLL-derived monocytes and tissue macrophages features during A. fumigatus infection, underlying the importance of BTK expression as a “guardian” of the innate immunity. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.